Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2009
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009EP1370270B1 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
12/02/2009EP1349841B1 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
12/02/2009CN101595093A Organic compounds
12/02/2009CN101591354A Functionalized ionic liquids, and methods of use thereof
12/02/2009CN101591332A Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
12/02/2009CN101591322A Cyclin dependent kinases inhibitor scutellaria flavonoid organic amine derivatives, preparation method and application thereof
12/02/2009CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009CN100564376C Method for preparing alfuzosin
12/02/2009CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
12/02/2009CN100564344C 2- and 2,5-substituted phenylketo-enols
12/01/2009US7626030 Compounds and methods of use
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009US7625926 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes
12/01/2009US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009CA2521258C 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors
12/01/2009CA2461100C 4-imidazolin-2-one compounds
11/2009
11/26/2009WO2009143153A1 Substituted pyrrolidine amides as modulators of the histamine h3 receptor
11/26/2009WO2009142969A1 Therapeutic lactams
11/26/2009WO2009142870A1 Compound comprising phenyl pyridine units
11/26/2009WO2009142867A1 Compound comprising phenyl pyridine units
11/26/2009WO2009141837A2 Process for preparing posaconazole and intermediates thereof
11/26/2009WO2009141292A1 Substituted heteroarylmethyl sulfonamides
11/26/2009WO2009141274A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
11/26/2009WO2009117036A3 Bioactive molecules from co-cultivation of microbes
11/26/2009WO2009115547A8 Trisubstituted 1, 2, 4 -triazoles as nicotinic acetylcholine receptor modulators
11/26/2009US20090292120 Benzimidazole compounds having gastric acid secretion inhibitory action
11/26/2009US20090292000 Pyrrolidine derivatives as prostaglandin modulators
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291979 Tricyclic-bridged piperidinylidene derivatives as delta opioid modulators
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291962 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor
11/26/2009US20090291936 Oxime derivative and preparations thereof
11/26/2009US20090289547 Compound comprising phenyl pyridine units
11/26/2009US20090289224 Compound comprising phenyl pyridine units
11/26/2009CA2724467A1 Therapeutic lactams
11/25/2009EP2123647A1 2-(amino-substituted)-4-phenyl pyrimidines useful for treating inflammatory diseases
11/25/2009EP2121670A2 Synthesis of selected stereoisomers of certain substituted alcohols
11/25/2009EP2121668A2 6,8-dichlorchroman-3-yl-1,3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
11/25/2009EP2121648A2 S1p receptor modulating compounds and use thereof
11/25/2009EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009EP2121619A2 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
11/25/2009EP2121583A1 Heteroaryl-substituted serine amides
11/25/2009EP2120578A1 Kinase inhibitor compounds
11/25/2009EP2041122B1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1828172B1 Pyrrole derivatives having crth2 receptor antagonist activity
11/25/2009EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009CN101588716A Substance capable of inhibiting cytokinin signaling
11/25/2009CN101585832A Preparing method for tri (beta-methyl glyceryl) isocyanurate
11/25/2009CN101585807A Azo compounds or their salts
11/25/2009CN101585799A Method for preparing unsymmetrical bis(indolyl)methane compound
11/25/2009CN101584691A Compounds effecting glucokinase
11/25/2009CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009CN100562516C Beta-amyloid protein production/secretion inhibitors
11/24/2009USRE41008 catalytic hydrogenation 5-arylnicotinic acids in presence of a palladium/ligand complex; intermediates for making N-alkylated amine; for crop protection, such as, fungicides, insecticides, herbicides or pesticides and drugs
11/24/2009US7622497 Such as -(Morpholin-4-yl)-ethyl gambogate; 2-Dimethylaminoethyl gambogate; N-[3-(4-Methyl-piperazin-1-yl)-propyl]gambogamide;N-(3-Morpholin-4-yl-propyl)gambogamide; Methyl 37,38-Dihydroxy-gambogate; Methyl 37,38-Dihydroxy-9,10-dihydro-10-morpholinyl-gambogate; anticarcinogenic agent
11/24/2009US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors
11/24/2009CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009CA2433197C Gyrase inhibitors and uses thereof
11/19/2009WO2009140624A2 Glucokinase activators
11/19/2009WO2009140164A1 6-aminonicotinamide derivatives as potent and selective histone deacetylase inhibitors
11/19/2009WO2009140144A1 Forms of crystalline lapatinib and processes for preparation thereof
11/19/2009WO2009139870A1 Oxo-imidazolyl compounds having antibacterial activity
11/19/2009WO2009139817A2 Crystalline pharmaceutical and methods of preparation and use thereof
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009138999A2 Process for the preparation of paroxetine hydrochloride
11/19/2009WO2009138338A1 Novel n-(2-amino-phenyl)-acrylamides
11/19/2009WO2009118473A3 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
11/19/2009WO2009112550A4 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
11/19/2009WO2009094442A3 5-fluoro pyrimidine derivatives as fungicides
11/19/2009WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009US20090286980 Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound
11/19/2009US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009US20090286828 2-amino-1-phenylethylcarboxamide derivatives
11/19/2009US20090286821 Inhibitors of tyrosine kinases
11/19/2009US20090286800 Glucokinase Activators
11/19/2009US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009US20090286767 Substituted quinolin-4-ylamine analogues
11/19/2009US20090286683 Benzoylpyrazole compounds and herbicides containing them
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009CA2724116A1 Glucokinase activators
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009CA2724003A1 Novel n-(2-amino-phenyl)-acrylamides
11/18/2009EP2119703A1 Novel indole derivative having inhibitory activity on i b kinase
11/18/2009EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009EP2118087A1 Pi 3-kinase inhibitors and methods of their use
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 694